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CASE REPORT Open Access
A case report of an unusual non-mucinous
papillary variant of CPAM type 1 with KRAS
mutations
Timco Koopman1,2* , Bart L. Rottier3, Arja ter Elst2 and Wim Timens2
Abstract
Background: congenital pulmonary airway malformation (CPAM) is the most frequent congenital lung disorder.
CPAM type 1 is the most common subtype, typically having a cystic radiological and histological appearance.
Mucinous clusters in CPAM type 1 have been identified as premalignant precursors for mucinous adenocarcinoma.
These mucinous adenocarcinomas and the mucinous clusters in CPAM commonly harbor a specific KRAS mutation.
Case presentation: we present a case of a 6-weeks-old girl with CPAM type 1 where evaluation after lobectomy
revealed a highly unusual complex non-mucinous papillary architecture in all cystic parts, in which both mucinous
clusters and non-mucinous papillary areas harbored the known KRAS mutation.
Conclusions: we found that a KRAS mutation thought to be premalignant in mucinous clusters only, was also
present in the other cyst lining epithelial cells of this unusual non-mucinous papillary variant of CPAM type 1,
warranting clinical follow-up because of uncertain malignant potential.
Keywords: Congenital pulmonary airway malformation (CPAM), Congenital lung disorder, Mucinous
adenocarcinoma, KRAS mutation
Background
Congenital pulmonary airway malformation (CPAM) is
the most frequent congenital lung disorder. Of the five
subtypes, CPAM type 1 is the most common. CPAM
type 1 typically has a cystic radiological and histological
appearance. Because of lung infection risk, CPAM-
afflicted lobes are surgically removed after birth. Add-
itionally, microscopic mucinous clusters have been iden-
tified as premalignant precursors for mucinous
adenocarcinoma. These mucinous adenocarcinomas and
the mucinous clusters in CPAM commonly harbor a
specific KRAS mutation. We present a case of CPAM
type 1 with a highly unusual complex non-mucinous
papillary architecture, in which both mucinous clusters




On the regular 20-week fetal anomaly ultrasound of a fe-
male infant, a macrocystic pulmonary malformation of
the right lung was found, interpreted as likely congenital
pulmonary airway malformation (CPAM). At 23 + 4
weeks of gestation, placement of a shunt was indicated
because of a mediastinal shift. Decompression of the left
lung was achieved by a shunt in the cysts draining into
the amnion. The infant was born spontaneously after
30 + 1 weeks of gestation, with a birthweight of 1.6 kg.
At birth, the shunt was dislocated and being cyanotic
and bradycardic the girl had to be mechanically venti-
lated. Initially this was successful, but after six hours
chest drainage was indicated again. Four days later the
CT-scan showed a multicystic malformation in the right
lower lobe, in line with the initial suspicion of CPAM,
without abnormal vascular supply. X-rays and CT scans
are shown in Fig. 1. Six weeks after birth, when the
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infant reached the weight of two kilograms, lobectomy
of the affected lobe was performed.
Pathology
The pathology findings are shown in Fig. 2. Gross exam-
ination showed a cystic lobe with multiple cysts larger
than 2 cm, the largest more than 3 cm. Microscopic
evaluation revealed cysts consistently lined with numer-
ous complex non-mucinous papillary projections, lined
with uniform non-ciliated cuboidal to low-columnar epi-
thelium with immature morphology and without cyto-
nuclear atypia, but without ciliated bronchial type
epithelial cells. Immunohistochemistry showed diffuse
strong positivity of TTF-1 (Thyroid Transcription
Factor-1) and Napsin A in the epithelial cells of the pap-
illary structures. Several interspersed small mucinous
Periodic Acid Schiff stain (PAS) positive clusters were
identified throughout the lesion. Additionally, the PAS
stain showed glycogenosis in the alveolar septa in the
non-involved part of the lobe, consistent with (variable
or possibly resolving) pulmonary interstitial glycogeno-
sis, which can be seen in relatively immature lung tissue
[1]. No morphological atypical or malignant foci were
found. The lesion was classified as a papillary variant of
CPAM type 1 because of the size of the cysts and the
architecture of the cyst wall with presence of a smooth
muscle layer, with the notion of the unusual non-
mucinous papillary morphology.
Molecular analysis
Molecular analysis was performed on three carefully
selected areas: firstly the mucinous clusters, secondly
the papillary areas and thirdly the pre-existent normal
appearing lung. These areas were manually annotated
by the pathologist on the corresponding Hematoxylin
and Eosin (H&E) slides, to ensure that the right areas
were sampled for molecular analysis. DNA extracted
(COBAS FFPE preparation kit, Roche) from Formalin-
fixed, Paraffin-embedded (FFPE) material of the three
selected areas was sequenced with Next Generation
Sequencing (NGS). Library preparation was performed
using a custom Ampliseq panel, which included the
hotspots of KRAS (codon 12, 13, 61, 117 and 146).
The library was sequenced on an Ion Personal Gen-
ome Machine™ (PGM™) System (Ion Torrent™). Ana-
lysis of the NGS data was performed with JSI
Nextseq software (JSI medical systems). Sequencing
showed a KRAS: c.35G > A p.(G12D) mutation in the
mucinous areas (20% neoplastic cells, variant allele
frequency 32%) as well as in the papillary areas (80%
neoplastic cells, variant allele frequency 20%). To ver-
ify the absence of the KRAS mutation in normal
appearing lung, a ddPCR using the KRAS screening
assay (ddPCR™ KRAS G12/G13 Screening Kit
#1863506, Biorad) was performed. The KRAS muta-
tion was not present in normal appearing lung (limit
of detection 2%).
Fig. 1 Chest X-ray after initial stabilization on the NICU ward a showed a large right lung with cyst-like appearance and a mediastinal shift to the
left. High resolution chest CT scans b and c showed a thick walled multicystic air filled process with a left-sided mediastinal shift. The chest drain
can be seen. Chest X-ray at the age of three months d showed slight post-operative thoracic cage deformity on the right, a clip in the right
hilum, and normal aeration of both the right and the left lung
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Follow-up
After surgery there were no per-operative or post-
operative complications. Post-operative control X-rays
showed a cystic residue, for which follow-up was indi-
cated. During follow-up at the age of 6 months the child
was thriving. In a multidisciplinary setting it was agreed
upon that based on the potential pathogenicity of the
mutations and the fact that the affected lung tissue was
completely removed, high resolution chest CT scans will
be performed at the ages of 1 and 3 years (arbitrarily
chosen), combined with clinical follow-up.
Discussion and conclusions
A congenital thoracic malformation (CTM), postnatally
diagnosed as a congenital pulmonary airway malforma-
tion (CPAM) and formerly called congenital cystic ade-
nomatoid malformation (CCAM), is the most frequent
congenital disorder of the lung accounting for 25% of all
congenital lung disorders [2]. EUROCAT data report a
prevalence of 1.05 per 10,000 pregnancies [3]. There are
five subtypes of CPAM, depending on typical clinical
and histological features [2, 4]. CPAM type 1 occurs
most frequently (60–70% of cases) and presents as one
or more medium to large cysts measuring more than 2
cm, usually limited to one lobe (95%). It is primarily
diagnosed in the first month of life. Because of the risk
of lung infections, CPAM-afflicted lobes are surgically
removed after birth. Histologic examination typically
shows thin-walled cysts lined with ciliated pseudostrati-
fied columnar epithelium [2]. These cysts can have
polypoid folds [5]. In the present case, histology revealed
a highly unusual complex non-mucinous papillary archi-
tecture in which the papillary projections were not lined
with bronchial epithelial ciliated cells as usual. To date,
this has not been described in literature. Fisher et al. de-
scribed a CPAM type 1 case with papillary architecture
[6]. However, they found large papillary projections in
an otherwise conventional CPAM and not the complex
papillary morphology as seen in the current case.
The use of elective surgery in non-respiratory compro-
mised children remains controversial [7]. Long-term sur-
vival after surgical removal of CPAM afflicted lobes is
usually very good. However, CPAM type 1 has been as-
sociated with the development of mucinous adenocar-
cinoma (formerly called mucinous bronchioloalveolar
carcinoma) [4, 5]. Mucinous clusters are present in one
third of CPAM type 1 cases and have been identified as
premalignant precursors for mucinous adenocarcinoma,
although the occurrence of carcinomatous transform-
ation is only < 1% [5, 8, 9]. In mucinous adenocarcinoma
Fig. 2 Gross examination showed a cystic lung a, with numerous complex non-mucinous papillary projections on histologic evaluation b-d.
Numerous mucinous clusters were identified c and d, arrows. Both these mucinous clusters as well as the papillary areas harbored KRAS c.35G > A
mutations. Histology images at 10x b, 50x c and 200x d magnification
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a specific KRAS mutation is found: KRAS c.35G > A,
p.(G12D) [10]. This KRAS mutation has also been found
in the mucinous clusters in CPAM [11], possibly being
premalignant precursors, and was also present our case.
Remarkably, the KRAS c35G > A mutation was also
found in the other, histologically benign appearing, non-
mucinous papillary areas. The clinical relevance of the
presence of this mutation in this setting is unclear, but is
likely also to be considered as indicating potential
malignancy.
In conclusion, we present a case of a 6-weeks-old girl
where lobectomy showed a CPAM type 1-like cystic le-
sion with a highly unusual papillary morphology, in
which both mucinous clusters as well as non-mucinous
papillary areas harbored a KRAS c.35G > A mutation, in
adults known to be associated with adenocarcinoma. Im-
portantly, we found that a KRAS mutation thought to be
premalignant in mucinous clusters only, was also present
in the other cyst lining epithelial cells of this unusual
non-mucinous papillary variant of CPAM type 1, war-
ranting clinical follow-up because of uncertain malignant
potential.
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